Ansu Satpathy, Stanford: “High-Throughput Genomics and Cancer Therapeutics”

Dr. Ansuman Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-director of the Immunotherapy Program in the Stanford Cancer Institute. Ansu’s research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. He is a co-founder of Immunai, Cartography Biosciences, Santa Ana Bio, and Prox Biosciences, and a venture partner at Wing Venture Capital.